PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.

Reported: August 3, 2022 Initiated: June 27, 2022 #D-1291-2022

Product Description

Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.

Reason for Recall

Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.

Details

Units Affected
9552 bottles
Distribution
Nationwide in the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 9552 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2022. Severity: Moderate. Recall number: D-1291-2022.